Antimicrobial stewardship strategies in wound care: evidence to support the use of dialkylcarb...
2021
J Wound Care. 30(4):284–296.
Evidens
Dokumentert effekt på forebygging og behandling av sårinfeksjon
Dokumentert i mer enn 40 kliniske studier og publikasjoner som omfatter over 7 000 pasienter. Sorbact® har blitt brukt i klinisk praksis med gode resultater i mer enn 30 år. I dag er Sorbact® til hjelp for pasienter i over 65 land rundt om i verden, og vi fortsetter det viktige arbeidet med å samle inn kliniske data.
Dette er et utvalg av vitenskapelige artikler om Sorbact®.
Filter
Viser 42 resultater
Antimicrobial Stewardship in wound care – Sorbact®
Sorbact® significantly reduced the incidence of SSI in caesarean sections
Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the...
2016
Surg Infect (Larchmt). 17(4):427-435.
Sorbact® significantly reduces bacterial burden in infected leg ulcers compared to a silver-containing dressing
Comparative study of two antimicrobial dressings in infected leg ulcers: A pilot study
2015
J Wound Care. 24(3):121-122, 124-127.
Sorbact® is proven effective in the management of chronic wounds
An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management
2008
Wounds UK. 4(2):10-18.
Studier
Intet resultat.
Meeting the challenges in pediatric wound care: Our 15-year experience with dialkylcarbamoyl c...
2022
Chronic Wound Care Management and Research. 2022;9:23-33.
Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressin...
2022
J Wound Care. 31:560-570.
Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wou...
2022
J Wound Care. 31:502-509.
Dialkylcarbamoyl chloride-coated versus alginate dressings after pilonidal sinus excision: A r...
2020
BJS Open. 4(2):225-231.
Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection followin...
2019
J Wound Care. 28(4):222-228.
A pilot feasibility randomised clinical trial comparing dialkylcarbamoylchloride-coated dressi...
2019
Int Wound J. 16(4):1-8.
Clinical efficacy of dialkylcarbamoylchloride-coated cotton acetate dressing versus combinatio...
2019
Dermatologic therapy. 32(5):e13047.
A prospective descriptive study of Cutimed Sorbact® used as a skin substitute for the treatmen...
2018
Prof Nurs Today. 22(2):33-38.
Dialkylcarbamoyl chloride dressings in the prevention of surgical site infections after nonimp...
2017
Ann Vasc Surg. 44:387-392.
Efficacy of dialkylcarbamoylchloride-coated dressing in management of colonized or infected ne...
2016
J Wound Ostomy Continence Nurs. 43(4):547-550.
The effect of a bacteria- and fungi-binding mesh dressing on the bacterial load of pressure ul...
2016
Wounds. 28(11):408-420.
Dialkylcarbamoyl chloride-impregnated dressing for the prevention of surgical site infection i...
2016
Arch Med Sci. 12(5):1036-1042.
A random prospective non-controlled clinical study of Cutimed Sorbact® as a skin substitute fo...
2015
Wound Healing Southern Africa. 2015;8:54-58.
Evidence is building to support using a DACC-coated antimicrobial wound contact layer with NPW...
2015
Wounds UK. 11(1):82-86.
Hydrogel-impregnated dressings for graft fixation: A case series
2015
J Wound Care. 24(7):326-328.
Adhesion of meticillin-resistant Staphylococcus aureus to DACC-coated dressings
2014
J Wound Care. 23(10):484, 486-488.
Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed...
2012
Eur J Clin Microbiol Infect Dis. 31(7):1523-1529.
Bacteria and fungus binding mesh in negative pressure wound therapy
2012
EWMA Journal. 12(3):27-31.
The use of DACC-coated dressings for the treatment of infected, complex abdominal wounds
2012
Wounds UK. 8(4):102-109.
Comparison of bacteria and fungus‐binding mesh, foam and gauze as fillers in negative pressure...
2012
Int Wound J. 10(5):597-605.
Use of DACC-coated dressings in diabetic foot ulcers: A case series
2011
Diabet Foot J. 14(3):133-137.
The diabetic foot: Managing infection using Cutimed Sorbact dressings
2010
Br J Nurs. 19(11):30, 32-36.
Cutimed® Siltec foam and Cutimed® Sorbact® gel dressings: A clinical audit
2010
Wounds UK. 6(1):130-136.
Evaluating Cutimed Sorbact: Using a case study approach
2009
Br J Nurs. 18(15):30, 32-36.
Open study on the topical treatment of interdigital fungal infections in diabetic patients
2009
J Wound Care. 18(11):470, 472-473.
An evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds
2007
Wounds UK. 3(4):113-119.
Using the principle of hydrophobic interaction to bind and remove wound bacteria
2006
J Wound Care. 15(4):175-180.
Clinical evaluation of Sorbact in the treatment of infected pressure sores
2004
Acta Vulnologica. 2(1-2):9-11.
Narrative litteraturstudier
Intet resultat.
Bacterial-binding dressings in the management of wound healing and infection prevention: a nar...
2019
J Wound Care. 28(6):370-382.
Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound in...
2017
J Wound Care. 26(3):107-114.
Posters
Intet resultat.
Evaluation of moisture donating capacity of six different wound gels in vitro
2019
EWMA. June 5-7, Gothenburg, Sweden.
Comparison of a novel non-medicated bacteria-binding dressing to silver dressings in the manag...
2015
SAWC Fall. September 12-14, Baltimore, USA
Bacteria and fungi binding mesh used as a NPWT wound filler for managing Pseudomonas aeruginos...
2014Konsensus og retningslinjer
Intet resultat.
Leukomed Sorbact for preventing surgical site infection
2021
NICE National Institute for Health and Care Excellence. 1-17.
Surgical site infection: Preventing and managing surgical site infection across health care se...
2020
J Wound Care. 29(Sup2b):1-72.
Birth-related wounds: Risk, prevention and management of complications after vaginal and caesa...
2020
J Wound Care. 29(Sup11a).
Implementing timers: The race against hard-to-heal wounds
2019
J Wound Care. 28(3):1-49
Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives
2018
J Wound Care. 27(Sup5):1-52.